The latest early phase cancer trials newsletter from the NIHR UCLH Clinical Research Facility (CRF) is out now.
In this edition, representatives from the UCL Experimental Cancer Medicine Centre provide an insight into their work and the partnership with the cancer clinical trials units.
Dr Rowan Miller gives an overview of a study looking at the effectiveness and safety of a drug in shrinking ovarian cancers.
Dr Rakesh Popat, Fatjon Dekaj and Dominic Patel provide updates on equality, diversity and inclusion (EDI) projects happening in early phase cancer research at the CRF.
The newsletter also highlights key recent publications and latest news from the CRF.
